1. Home
  2. VTRS vs DUOL Comparison

VTRS vs DUOL Comparison

Compare VTRS & DUOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTRS
  • DUOL
  • Stock Information
  • Founded
  • VTRS 1961
  • DUOL 2011
  • Country
  • VTRS United States
  • DUOL United States
  • Employees
  • VTRS N/A
  • DUOL N/A
  • Industry
  • VTRS Medicinal Chemicals and Botanical Products
  • DUOL Computer Software: Prepackaged Software
  • Sector
  • VTRS Health Care
  • DUOL Technology
  • Exchange
  • VTRS Nasdaq
  • DUOL Nasdaq
  • Market Cap
  • VTRS 11.1B
  • DUOL 13.3B
  • IPO Year
  • VTRS N/A
  • DUOL 2021
  • Fundamental
  • Price
  • VTRS $10.37
  • DUOL $311.46
  • Analyst Decision
  • VTRS Hold
  • DUOL Buy
  • Analyst Count
  • VTRS 6
  • DUOL 18
  • Target Price
  • VTRS $11.17
  • DUOL $407.76
  • AVG Volume (30 Days)
  • VTRS 7.1M
  • DUOL 1.2M
  • Earning Date
  • VTRS 11-06-2025
  • DUOL 11-05-2025
  • Dividend Yield
  • VTRS 4.64%
  • DUOL N/A
  • EPS Growth
  • VTRS N/A
  • DUOL 73.11
  • EPS
  • VTRS N/A
  • DUOL 2.46
  • Revenue
  • VTRS $14,115,700,000.00
  • DUOL $885,152,000.00
  • Revenue This Year
  • VTRS N/A
  • DUOL $38.77
  • Revenue Next Year
  • VTRS $1.61
  • DUOL $25.92
  • P/E Ratio
  • VTRS N/A
  • DUOL $127.04
  • Revenue Growth
  • VTRS N/A
  • DUOL 39.51
  • 52 Week Low
  • VTRS $6.85
  • DUOL $256.63
  • 52 Week High
  • VTRS $13.55
  • DUOL $544.93
  • Technical
  • Relative Strength Index (RSI)
  • VTRS 61.57
  • DUOL 45.98
  • Support Level
  • VTRS $10.30
  • DUOL $301.74
  • Resistance Level
  • VTRS $10.52
  • DUOL $344.00
  • Average True Range (ATR)
  • VTRS 0.21
  • DUOL 16.85
  • MACD
  • VTRS 0.05
  • DUOL -1.96
  • Stochastic Oscillator
  • VTRS 81.82
  • DUOL 18.96

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About DUOL Duolingo Inc.

Duolingo Inc is a technology company that develops a mobile learning platform to learn languages and is the top-grossing app in the Education category on both Google Play and the Apple App Store. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated master new material, and achieve their learning goals. Its solutions include the Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has four predominant sources of revenue; time-based subscriptions, in-app advertising placement by third parties, and the Duolingo English Test, and In-App Purchases.

Share on Social Networks: